Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Salvia Investment GmbH is named as a reporting person in SEC Form 4 filings. OQRO lists 5 transactions filed with the SEC under this name, the latest on Nov 2, 2026, each linked to the official Form 4.
Disclosures on record
5
Companies involved
1
As of the latest filing on , Salvia Investment GmbH reported holding 9,264,301 shares of Bambusa Therapeutics (BBTX), worth about $149M at the last close of $16 (Nov 13, 2026). In the last 12 months, Salvia Investment GmbH bought $6M in 1 open-market purchase.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Bambusa Therapeutics BBTX | 9,264,301 | 9.26M direct | $16 | $149M | Nov 2, 2026 |
Is this Salvia Investment GmbH’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Bambusa TherapeuticsBBTX
5 disclosures · Nov 2026 · 1 bought
Nov 2, 2026Bought~$6M
DetailsOfficial recordNov 2, 20264.77M
DetailsOfficial recordNov 2, 20263.14M
DetailsOfficial recordNov 2, 20261.47M
DetailsOfficial recordNov 2, 2026161K
DetailsOfficial recordOn the latest SEC Form 4, dated Nov 2, 2026, Salvia Investment GmbH reported holding 9,264,301 shares of Bambusa Therapeutics (BBTX). At the last close of $16 on Nov 13, 2026, that is about $149M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Salvia Investment GmbH reported 1 open-market purchase worth $6M, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Salvia Investment GmbH bought shares on the open market in 2026.
In SEC filings since 2026: the latest open-market purchase is from 2026; no open-market sale is on record.
Bambusa Therapeutics (BBTX), from 2026 to 2026: 1 purchase and 0 sales.
Salvia Investment GmbH bought shares on the open market in 2026.
Salvia Investment GmbH reported 1 open-market purchase and 0 sales since 2026; purchases in 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $6M1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Salvia Investment GmbH reported 1 open-market purchase and 0 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.